Congenital symblepharon is a rare eye condition present at birth where the eyelid lining sticks to the surface of the eye. It can cause eye irritation, tearing, limited eye movement, and trouble opening the eyelid fully. Babies and children are most often affected, and features may be noticed in the newborn period or early childhood. Many people with congenital symblepharon do well, and the condition is not life-threatening. Treatment often involves lubricating drops or ointment, and surgery may be needed to release the adhesion and improve vision and comfort.
Overview
Congenital symblepharonSymptoms
Congenital symblepharon shows a visible tissue band tethering the inner eyelid to the eye surface. Features can include limited eyelid or eye movement, difficulty opening the eye, irritation, tearing, and blurred vision if the clear front surface is involved.
Outlook and prognosis
Most people with congenital symblepharon do well when it’s treated early, especially if vision is protected and the eye surface stays moist. Mild bands may only need lubrication and monitoring. More complex adhesions sometimes need surgery, and outcomes improve with consistent follow‑up.
Causes and risk factors
Congenital symblepharon usually stems from prenatal eyelid–conjunctival developmental disruptions, amniotic bands, or in‑utero inflammation, and may occur within genetic syndromes. Risk factors for congenital symblepharon include relevant family history, maternal infections, teratogenic exposures, and complications like premature rupture of membranes.
Genetic influences
Genetics play a limited role in congenital symblepharon; most cases stem from prenatal surface injury, infections, or amniotic adhesions. Inherited single-gene causes are rare, though some syndromes can include it. Family history usually doesn’t predict risk.
Diagnosis
Diagnosis of congenital symblepharon is usually clinical: an eye specialist sees eyelid–eye surface adhesion on exam with slit-lamp. Imaging of the front of the eye and, when syndromic features exist, genetic tests can refine severity and cause.
Treatment and drugs
Treatment for congenital symblepharon focuses on freeing the eyelid from the eye surface and preventing it from sticking again. Care may include lubricating drops or ointments, protective contact lenses, and surgery with grafts, followed by careful eyelid stretching and regular follow-up.
Symptoms
Congenital symblepharon can affect how the eyelid moves and how the eye surface feels from birth, sometimes making the eye look partly stuck to the lid. Features vary from person to person and can change over time. Parents or caregivers may notice early features of congenital symblepharon like a small band of tissue between the inner eyelid and the white of the eye, extra tearing, or sensitivity to light.
In congenital symblepharon, a small band of tissue links the inner eyelid to the white of the eye. It can be present in one eye or both. The connection may be thin and hard to see or thicker and more obvious.
The lid may not open as widely as the other side, making the eye look partly held down. Blinks can seem tight or incomplete. This can leave the surface less protected and more easily irritated.
Congenital symblepharon can limit how far the eye looks up, down, or to the sides. Some children turn their head to follow objects instead. This is often subtle unless the adhesion is broad or near the clear center of the eye.
The eye can feel gritty, sore, or itchy and may look red. Wind, heat, or smoke can make this worse. Discomfort may come and go during the day.
How people usually first notice Congenital symblepharon?
Parents or clinicians usually spot the first signs of congenital symblepharon soon after birth during a newborn eye exam, noticing a thin band of tissue tethering the inner eyelid to the eyeball or the corner of the eye that doesn’t move freely. You might see the eyelid look “stuck” to the eye surface, trouble opening the eye fully, or irritation with tearing if the adhesion rubs the cornea. In some babies it’s subtler and is first noticed later at routine checkups when doctors look closely at eyelid movement and the conjunctiva; this is how congenital symblepharon is first noticed for many families.
Types of Congenital symblepharon
Congenital symblepharon means some of the inner eyelid tissue is stuck to the white part of the eye from birth, which can pull on the eyelid and limit eye movement. People with congenital symblepharon can have different patterns based on where the adhesions sit and how deep they go. Symptoms don’t always look the same for everyone. Clinicians often describe them in these categories: location (upper vs lower lid), extent (partial vs total), and depth (anterior vs posterior), and understanding the types of congenital symblepharon helps guide treatment.
Upper lid variant
Adhesions connect the upper eyelid lining to the eye surface, often noticed when looking down. This can cause a pulling sensation, upper lid droop, or trouble fully opening the eye. Vision may blur if the cornea gets irritated.
Lower lid variant
Bands form between the lower eyelid lining and the eye, more obvious when looking up. People may feel tightness, irritation, or see a visible web in the lower corner. Dryness and tearing can happen if the eyelid can’t move smoothly.
Partial adhesion
Only a small segment of the eyelid is attached to the eye, usually at the corner or a short strip. Many living with congenital symblepharon notice mild discomfort or cosmetic concerns rather than major vision issues. If the band grows or pulls the eyelid, symptoms can increase.
Total adhesion
A broad area of the eyelid sticks to the eye, sometimes limiting eye movement or closing. This can cause significant irritation, double vision, or reduced vision if the cornea is involved. Early specialist care is important to protect the eye surface.
Anterior adhesion
The attachment sits near the front surface of the eye and eyelid lining. Irritation, redness, and a feeling of something in the eye are common. These are often easier to reach surgically if treatment is needed.
Posterior adhesion
The band reaches deeper toward the back of the eyelid lining, which can restrict eye motion more. People may notice pulling with side gaze and persistent dryness. These variants of congenital symblepharon can be harder to separate and may recur.
What genetics can tell you about symptoms
Some people with congenital symblepharon have eyelid tissue that adheres to the eye surface from birth, causing limited eye movement, irritation, tearing, or light sensitivity. When linked to genetic conditions like ectodermal dysplasia or epidermolysis bullosa, the adhesion and scarring tend to be more severe.
Causes and risk factors
Congenital symblepharon usually begins in the womb when the eyelid lining sticks to the eye surface during development. It can occur alone or with rare genetic syndromes due to inherited or new gene changes. Biological factors like amniotic bands can raise the chance, but the causes of congenital symblepharon are often unknown. Having risk factors doesn’t mean you’ll definitely develop the condition. There are no proven lifestyle risks in pregnancy for congenital symblepharon, and family history matters mainly when a related syndrome runs in the family.
Environmental and biological risk factors
This section looks at what can raise the chance of congenital symblepharon before birth. People often ask about environmental risk factors for congenital symblepharon during pregnancy, and how they differ from body-based factors. Doctors often group risks into internal (biological) and external (environmental). Below are factors linked with a higher likelihood.
In early pregnancy, the eyelids naturally fuse and later open; if that opening is incomplete, the lid and eye surface can remain stuck. This biological variation raises the chance of congenital symblepharon.
Thin tissue bands between the eyelids at birth show that eyelid separation was disrupted. When these bands touch the eye surface, they can encourage a lid–eye adhesion.
Strands from a torn amniotic sac can tether the eyelid or eye surface while the fetus is growing. This tethering may scar the surface and create a persistent adhesion seen in congenital symblepharon.
Damage or early rupture of the membranes around the fetus can expose the eye to rubbing strands or irritation. This increases the chance of the eyelid and eye surface sticking before birth.
Genetic risk factors
Genetic factors can play a role in how the eyelids and eye surface separate before birth. For some families, congenital symblepharon appears as part of rare inherited syndromes that disrupt this process. Doctors have reported genetic causes of congenital symblepharon most often within the cryptophthalmos/Fraser syndrome spectrum and certain TP63-related syndromes. Carrying a genetic change doesn’t guarantee the condition will appear.
Fraser/FREM genes: Changes in genes such as FRAS1, FREM2, or GRIP1 (part of the Fraser syndrome spectrum) can disrupt eyelid and conjunctival separation. These are usually inherited in an autosomal recessive pattern and have been linked to congenital symblepharon within the cryptophthalmos spectrum. Siblings have a 1 in 4 chance of being affected when both parents are carriers.
TP63 syndromes: Variants in TP63 (such as those causing AEC/Hay‑Wells and related conditions) can lead to eyelid bands and eye‑surface adhesions, and some newborns show symblepharon. These syndromes often follow an autosomal dominant pattern, so each child has up to a 1 in 2 chance of inheriting the change. Features can range from limited ocular adhesions to broader skin, hair, or nail differences.
Autosomal recessive: When a condition is recessive, a baby must receive one nonworking copy of the gene from each parent. Parents are usually healthy carriers, and each pregnancy has a 25% (1 in 4) chance of an affected child. This pattern applies to many Fraser‑spectrum causes of congenital symblepharon.
Autosomal dominant: In dominant conditions, a single gene change can be enough to cause features. An affected parent has a 50% (1 in 2) chance to pass on the change to each child. In these families, eye‑surface adhesions may occur alone or alongside other differences.
De novo changes: Sometimes a genetic change happens for the first time in a child, with no prior family history. These new (de novo) variants have been reported in TP63‑related and other ocular‑development syndromes. Future children of the affected person can inherit the change, even if their parents do not have it.
Variable expressivity: The same gene change can cause different features in different family members. Risk is not destiny—it varies widely between individuals. In some, congenital symblepharon is the main finding; in others, broader eye or skin features are present.
Lifestyle risk factors
Congenital symblepharon is present at birth; lifestyle habits do not cause it, but they can influence symptoms, comfort, and the likelihood of adhesions worsening or recurring after treatment. Understanding how lifestyle affects congenital symblepharon helps families and patients make daily choices that reduce irritation and mechanical traction on the eye. The elements below focus on behaviors that can modify ocular surface friction, inflammation, and postoperative outcomes.
Frequent rubbing increases mechanical traction on the conjunctiva and can worsen adhesions or inflammation. Use cold compresses and gentle lid hygiene to relieve itch without rubbing.
Poorly fitted lenses or lax hygiene can irritate the ocular surface and promote scarring that tightens adhesions. Only use contacts under specialist guidance, or avoid them if advised.
Long, uninterrupted screen use lowers blink rate, drying the ocular surface and increasing friction along the adhesion line. Follow the 20-20-20 rule and use lubricating drops as prescribed.
Skipping lubricants, ointments, or prescribed lid-stretching/scleral shell routines can let tissues re-stick after separation procedures. Consistent use helps maintain comfort and separation.
Risk prevention
Because congenital symblepharon is present at birth, there’s usually no way to prevent it from occurring in the first place. Prevention focuses on protecting the eye’s surface, preserving vision, and lowering the chance that adhesions worsen over time. Recognizing early symptoms of congenital symblepharon, like a stuck eyelid or limited eye movement, can prompt quicker care. Prevention works best when combined with regular check-ups.
See a pediatric eye specialist early to map the adhesions and check vision development. Early guidance helps time treatments and lowers the chance of long-term vision problems.
Preservative-free eye drops or ointment can reduce friction between the eyelid and eye. This helps protect the surface and may limit worsening of congenital symblepharon.
Keep hands away from the eyes and minimize smoke, dust, and strong wind. Less irritation lowers inflammation that can tighten adhesions.
Treat pink eye or eyelid infections quickly to protect healing tissues. Good handwashing and avoiding shared towels reduce the spread of germs that could aggravate congenital symblepharon.
Transmission
Congenital symblepharon is present at birth and is not infectious—it cannot be passed from one person to another. In most people, there is no genetic transmission of congenital symblepharon; it happens sporadically during early eye development before birth. Rarely, congenital symblepharon occurs as part of a broader genetic syndrome, and how congenital symblepharon is inherited then follows the inheritance pattern of that condition. If this runs in a family or appears with other birth differences, a genetics specialist can explain how congenital symblepharon is inherited in that context.
When to test your genes
Consider genetic testing if symblepharon appears at birth with other eye or facial differences, a family history of similar findings, or signs suggesting a broader syndrome. Test when results could change care—guiding eye surgery timing, monitoring for associated issues, or informing family planning. Seek genetics referral if the diagnosis is uncertain.
Diagnosis
Day-to-day, congenital symblepharon can make blinking uncomfortable, cause tearing, or limit how the eye moves, even in infancy. For many families, the diagnosis of congenital symblepharon is based on what the eye specialist sees at the slit-lamp and during a gentle eyelid exam. Getting a diagnosis is often a turning point toward answers and support. Early checks help protect vision and guide timing for any procedures.
Pediatric and eye specialists look for tissue bridges between the eyelid lining and the white of the eye. They note where the adhesions are and how deep the eyelid pocket (fornix) is. This helps assess comfort and risk to vision.
A special microscope lets the doctor view the eyelid lining and eye surface in detail. This shows the exact location and thickness of the adhesions. It also helps distinguish congenital patterns from scarring seen in acquired cases.
The eyelid is gently flipped to inspect the hidden inner surface. Doctors map how far the adhesion extends and whether the eyelid pocket is shortened. This mapping supports planning if a release procedure is needed.
A safe orange dye highlights dry spots, tiny scratches, or rubbing from the adhesion. Under blue light, problem areas glow so they’re easier to see. This helps monitor healing after treatment as well.
Stages of Congenital symblepharon
Congenital symblepharon does not have defined progression stages. It’s present from birth and often stays fairly stable, though the small bands of tissue can tighten or cause irritation as the eye and eyelids grow; early symptoms of congenital symblepharon can include mild redness, watering, or a sense that the lid is tethered to the eye. Doctors usually start with a conversation about your child’s history and a careful eye exam, sometimes using a slit-lamp (a bright, focused light) to map where the tissue is joined. Monitoring typically involves follow-up exams, photos, and noting any changes in eye comfort or movement, with imaging or specialist referral if surgery is being considered.
Outlook and prognosis
Daily routines often adapt as children with congenital symblepharon grow—eye lubrication drops, sun hats, and regular eye checks become part of life, while school and play continue with a few sensible adjustments. The outlook is not the same for everyone, but most people do well when the eyelid–eye surface connection is recognized early and managed by an eye specialist. Vision is the main concern: if the adhesion tugs on the cornea or limits eyelid movement, it can blur sight or lead to amblyopia (“lazy eye”) in childhood. Serious complications like persistent corneal scarring are uncommon with modern care, and congenital symblepharon itself does not affect life expectancy.
Understanding the prognosis can guide planning and helps families balance watchful care with normal activities. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, including how carefully the eye surface is protected from dryness, infections, and irritation. Some people experience only a small tether that stays stable, while others notice the band tightens as the eye grows, which may call for surgery. Early symptoms of congenital symblepharon can be subtle—tearing, light sensitivity, or a lid that doesn’t fully open—so early eye exams and treatment for amblyopia can protect vision.
With ongoing care, many people maintain comfortable eyes and good sight into adulthood. When surgery is needed, outcomes are generally favorable, though a second procedure may be needed if the tissue reattaches during healing. Support from friends and family can make the day-to-day routine—drops, shields at night after surgery, follow-up visits—easier to keep up with. Talk with your doctor about what your personal outlook might look like, including risks to the cornea and the best timing for any procedure.
Long-term effects
Congenital symblepharon can affect how the eyelids and the eye surface move together over time, which can influence comfort and vision. Long-term effects vary widely, and depend on how much of the lid and eye surface are joined. What families think of as early symptoms of congenital symblepharon are often early-life features like reduced eye opening, eye surface irritation, and vision development challenges.
In infancy and childhood, partial lid-to-eye adhesion can blur or block vision, raising the risk of amblyopia and astigmatism. Earlier depth and clarity issues can carry into school years if vision is not evenly stimulated.
Adhesion can disturb the tear film and the eyelid’s sweep across the eye. Dryness, stringy discharge, and a gritty feel may persist off and on.
Tethering between the eyelid lining and the eye’s surface can restrict gaze and make looking to the sides feel tight. Some notice discomfort with wide eye movements.
Long-standing friction and exposure can lead to surface scarring or new blood vessels on the cornea. This can reduce sharpness and increase light sensitivity.
How is it to live with Congenital symblepharon?
Living with congenital symblepharon often means dealing with eyes that feel persistently dry, irritated, or tight, especially when blinking or looking to the side. Daily routines may include frequent lubricating drops, careful eyelid hygiene, and regular eye checks to protect the cornea and preserve vision; some people may need surgeries over time to release scar bands or improve eyelid movement. School, work, and driving can be manageable with plan‑ahead strategies like carrying drops, using humidifiers, and taking screen breaks, though wind, smoke, or bright light can make symptoms flare. Family members, teachers, and coworkers can help by understanding the need for eye rest, accommodating seating or lighting, and watching for signs of discomfort so support feels practical, not pitying.
Treatment and drugs
Treatment for congenital symblepharon focuses on freeing the eyelid from the eye surface, protecting the cornea, and preventing the scar from coming back. In mild cases, lubricating eye drops or ointments, eyelid stretching, and soft bandage contact lenses can reduce irritation and keep the eyelid from sticking, while doctors monitor vision and eye growth closely. When the eyelid is firmly attached or vision is at risk, surgery is often recommended to release the adhesion and reconstruct the inner eyelid lining; surgeons may use tissue grafts (such as amniotic membrane) and place temporary spacers or special contact lenses to help healing. After surgery, frequent lubrication, anti‑inflammatory drops, and careful follow‑up are key to lower the chance of recurrence, and patching or glasses may be used if there’s amblyopia (lazy eye). Not every treatment works the same way for every person, so your doctor may tailor the plan to your child’s age, the severity of the symblepharon, and how the eye responds over time.
Non-drug treatment
Living with congenital symblepharon can mean irritation, a feeling of pulling when you blink, or trouble opening the eye fully. Early symptoms of congenital symblepharon may be subtle—like dryness that doesn’t improve with usual drops—or more noticeable, such as the eyelid seeming “stuck” to the eye. Non-drug treatments often lay the foundation for comfort, protection, and preventing the adhesion from getting tighter. Depending on age and severity, care ranges from simple moisture support to specialized lenses, rings, and surgery.
Preservative-free artificial tears and nighttime ointment reduce friction and dryness. They can ease irritation and help protect the surface when lids and eye rub.
Moisture chamber glasses or sleep shields keep humidity around the eye. This can reduce dryness and discomfort and make blinking smoother.
Large-diameter lenses vault over the cornea and hold a fluid cushion against the eye. They can protect the surface, improve comfort, and sometimes help keep the lid and eye from sticking.
A custom ring or clear conformer helps keep the inner eyelid fold (fornix) open. It can prevent tightening of adhesions and support healing after procedures.
Your genes may have an impact on how drugs work for you
Some medicines used during eye surgeries or to manage inflammation can work differently based on your genes, affecting drug breakdown speed and side‑effect risk. Genetic differences in enzymes, like CYP450, may guide dose choices or alternative options for safer care.
Pharmacological treatments
Medicines for congenital symblepharon focus on comfort, eye‑surface protection, and calming irritation; surgery is sometimes needed for adhesions that limit eye movement or comfort. Early symptoms of congenital symblepharon, like gritty eyes or redness, often improve with lubricants and anti‑inflammatory drops. Drugs that target symptoms directly are called symptomatic treatments. Your eye specialist will tailor choices to your age, symptoms, and how the eye surface looks on exam.
Carboxymethylcellulose or hypromellose drops add moisture and reduce friction. Petrolatum–mineral oil ointment can be used for extra protection, especially in dry or windy conditions. These are safe for frequent, long‑term use.
Prednisolone acetate 1% or fluorometholone can quickly calm redness and swelling during flares. Short courses lower scarring risk from ongoing irritation. Drops are tapered under supervision to reduce side‑effect risks like higher eye pressure.
Erythromycin ointment at bedtime or moxifloxacin drops may be used if the surface is scraped or after procedures. This helps prevent infection while the tissue heals. Courses are usually brief.
Olopatadine or ketotifen ease itch and watering if allergies make symptoms worse. Reducing rubbing protects the delicate lining that’s already tethered by the symblepharon. Use once or twice daily during allergy seasons as advised.
Genetic influences
Genetic causes of congenital symblepharon are uncommon; most cases happen sporadically and aren’t inherited. Often, a one-off disruption while the eyelids and the eye’s surface are forming before birth leads to areas of sticking, with no family link. Still, congenital symblepharon can occur as part of rare genetic syndromes that affect the eyelids, skin, mouth, or limbs, where a gene change can alter how these tissues separate during early development. Family history is one of the strongest clues to a genetic influence. Doctors are more likely to suggest genetic counseling or testing when other birth differences are present—such as notable eye shape changes, facial clefting, or skin and nail findings—or when multiple relatives are affected. Even when a gene change is found, how much it affects someone can vary widely within the same family. If there are no other features and no family history, the likelihood of an inherited cause is low, though your care team can help decide whether any genetic evaluation makes sense for you.
Is Congenital symblepharon genetic?
Genetics play a limited role in congenital symblepharon; most cases stem from prenatal surface injury, infections, or amniotic adhesions. Inherited single-gene causes are rare, though some syndromes can include it. Family history usually doesn’t predict risk.
Pharmacogenetics—how genetics influence drug effects
Care for congenital symblepharon often includes preservative‑free lubricating drops, short courses of anti‑inflammatory medication, and, around surgery, medicines that reduce scarring. Genes can influence how quickly you process certain pain relievers or immune‑calming drugs, which can change how well they work and the chance of side effects. For example, some people break down codeine or tramadol very slowly or very fast, so they may need a different pain plan after eye procedures. If tacrolimus or cyclosporine is used to quiet surface inflammation or protect a graft, inherited differences in drug‑handling enzymes can affect the dose needed, especially with tacrolimus. When congenital symblepharon is part of a genetic condition that makes the skin and eye surface fragile, the care team may avoid harsh preservatives and choose gentler medicines to support healing. Routine genetic testing to guide these medicines isn’t required, but it may be considered if dosing is hard to balance or side effects occur. Tell your eye team about any strong reactions you’ve had to pain relievers, anesthetics, or past eye drops so they can tailor treatment of congenital symblepharon safely.
Interactions with other conditions
When a child has congenital symblepharon along with other eye surface problems like allergies or blepharitis, the added inflammation can increase redness and tethering, making blinking and eye movement more uncomfortable. A condition may “exacerbate” (make worse) symptoms of another, so flare-ups of allergic conjunctivitis or dry eye can tighten the adhesion and raise the chance of corneal irritation. Congenital symblepharon can also appear within broader syndromes that affect the eyelids and skin; in those settings, the risk of vision issues like astigmatism or lazy eye (amblyopia) is higher, especially if droopy lids or corneal haze are also present. Families sometimes notice that when a respiratory virus or eczema is active, eye rubbing increases and the eye sticks more, while calmer skin and allergy control eases symptoms. Because early symptoms of congenital symblepharon can look like ordinary pink eye, coexisting infections may delay diagnosis or blur which problem needs treatment first. Coordinated care among eye specialists, dermatology, and genetics helps align treatments and can lower the risk of recurrence after surgical repair.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies born with parts of the eyelid stuck to the surface of the eye, making it hard to open the eye fully or move it comfortably. Family members might recall an infant whose eye never seemed to open all the way, or a child who tilted their head to see around a patch of tissue bridging the lid and the eye. These early stories point to what we now call congenital symblepharon, a condition present at birth in which the inner eyelid adheres to the white of the eye or the clear surface.
First described in the medical literature as eyelid-to-eye adhesions, early reports focused on what doctors could see: a band of tissue limiting blinking and eye movement. Before modern tools, people with congenital symblepharon were often managed by careful observation or simple separation procedures, sometimes with mixed results. As surgical techniques improved in the late 19th and early 20th centuries, surgeons began to document methods to gently release the adhesion and protect the eye’s surface afterward.
In recent decades, knowledge has built on a long tradition of observation. Clinicians recognized that congenital symblepharon isn’t a single story—it can appear alone, follow prenatal injury or infection, or occur alongside other eye surface conditions present at birth. With the advent of the slit-lamp exam and better imaging, doctors could map the exact location of the adhesion and plan treatment that preserves the cornea and eyelid function.
Over time, descriptions became clearer about differences between congenital symblepharon and adhesions that develop later in life from burns, autoimmune disease, or severe eye inflammation. This mattered for families because early symptoms of congenital symblepharon—like difficulty opening the eye, tearing, or light sensitivity—may be subtle, and early identification helps guide timing of care.
Advances in pediatric eye surgery, anesthesia, and tissue grafting transformed outcomes. Surgeons learned to use thin grafts from the patient’s own mouth lining or donor tissue to cover the raw surface after release, lowering the chance that the eyelid would reattach. Doctors also refined aftercare with lubricants and small conformers to keep the tissues apart while healing.
Understanding has continued to evolve alongside genetics and prenatal care. While most cases of congenital symblepharon are isolated and not inherited, recognizing when it appears with broader facial or eyelid differences has helped teams coordinate care across specialties. Today, the history of congenital symblepharon reflects steady progress—from simple descriptions of a stuck eyelid to tailored approaches that protect vision and comfort from infancy onward.